CM
NVNO

CM Management’s enVVeno Medical NVNO Stock Holding History

CM Management’s Portfolio NVNO Stock Details NVNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$362K Hold
35,714
– – 0.3% 66
2025
Q4 		$401K Buy
35,714
+18,571
+108% +$361K 0.34% 55
2025
Q3 		$544K Buy
+17,143
New +$1.75M 0.45% 55

Other funds holding NVNO

KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

CM Management's NVNO Position: Q1 2026 in Review

CM Management held its enVVeno Medical (NVNO) position steady in Q1 2026 at 35,714 shares worth $362K. The position accounts for 0.3% of the portfolio, ranked #66.

CM Management first reported a position in NVNO in Q3 2025 and has held it in 3 quarters since. The position peaked at $544K in Q3 2025. 17 funds tracked by Wall St. Rank hold NVNO as of Q1 2026.

  • CM Management held 35,714 shares of enVVeno Medical worth $362K as of Q1 2026.
  • CM Management left its enVVeno Medical share count unchanged in Q1 2026.
  • enVVeno Medical made up 0.3% of CM Management's portfolio in Q1 2026, its #66 holding.
  • CM Management first reported a position in enVVeno Medical in Q3 2025 and has held it in 3 quarters since.
  • CM Management's enVVeno Medical position peaked at $544K in Q3 2025.
  • 17 funds tracked by Wall St. Rank held enVVeno Medical as of Q1 2026.

Based on CM Management's 13F filing for Q1 2026, filed 8 May 2026.